Examine the Effects of Mindfulness in Woman With a History of Child Adversity
EMMA
Pilot Randomized Controlled Trial Examining the Effects of Daily Mindfulness in Woman With a History of Child Adversity
2 other identifiers
interventional
72
1 country
1
Brief Summary
The aim of this pilot Randomized Controlled Trial (RCT) is to test whether brief mindfulness-based practices will improve well-being and health in women (age 30-50) with a history of early life adversity. Following a baseline visit (remotely via Zoom), participants are randomized (50% probability) to either a Mindful Activity group or a Mindful Awareness group. In the Mindful Activity group, participants will complete brief (approximately 5-10 min) audio-guided mindfulness practices twice a day (morning and evening) for 8 weeks using the study app. This is followed by a brief survey about their current thoughts and feelings. In the Mindful Awareness group, participants are asked to be mindful (pay attention) to their thoughts and feelings twice a day (morning and evening) for 8 weeks using the study app. After the 8-week intervention period, all participants complete a follow-up visit (remotely). Primary goals of the pilot RCT are to test acceptability, feasibility, and adherence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 10, 2022
CompletedFirst Posted
Study publicly available on registry
February 24, 2022
CompletedStudy Start
First participant enrolled
June 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 19, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 19, 2024
CompletedMay 4, 2025
May 1, 2025
1.9 years
February 10, 2022
May 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Acceptability of the intervention will be measured with an adapted version of the Treatment Acceptability Questionnaire (TAQ).
The Treatment Acceptability Questionnaire (TAQ) is a six-item scale assessing whether participants view their assigned intervention as acceptable, ethical, and effective. Items are rated on a 7-point Likert scale (e.g., 1 "very unacceptable" to 7 "very acceptable), with a possible score range from 6 to 42. Higher scores indicate better treatment acceptability and positive perceptions of the treatment. A total mean score of at least 24 will indicate sufficient acceptability of the intervention.
Assessed at post-intervention, approximately 8 weeks from baseline
Feasibility, as indicated by numbers of participants screened (completed web-based screener and phone screener), eligible based on web-based screener and phone screener, consented, randomized to treatment, and retained at follow-up.
Feasibility outcomes will include: \>70% of eligible participants (passed web-based and phone screener) will be consented, \>70% of consented participants will pass further baseline screening procedures and will be randomized to treatment, \>70% of participants who are randomized to treatment will be retained at follow-up. Reasons for ineligibility and drop out will also be assessed.
Anticipated study period of 12 months
Adherence, as measured by the percentage of assigned and completed intervention group practices.
Completion of at least 50% of assigned intervention group practices (Ecological Momentary Assessments for Mindful Awareness group; mindfulness practices for Mindful Activity group) is considered acceptable.
Baseline to follow-up, an anticipated 8 weeks
Secondary Outcomes (1)
Change in depressive symptoms, as measured by the total score on the 9-item Patient Health Questionnaire (PHQ-9).
Baseline to post-intervention, an anticipated 8 weeks
Study Arms (2)
Mindful Activity group
EXPERIMENTALParticipants complete mindfulness and compassion-based practices via the study app.
Mindful Awareness group
SHAM COMPARATORParticipants monitor and report their thoughts and feelings via the study app.
Interventions
The app-based (audio-guided) interventions consist of mindfulness and compassion-based practices that are selected to maximize their effect on stress targets. Interventions include, for example, practices that focus on the breath/body (e.g., 3-minute breathing space; compassionate body scan; five senses mediation), on increasing participants' inner resources (e.g., imaging a safe person or safe place), on reducing negative affect (e.g., self-compassion and acceptance-based practices), or on increasing positive emotions (e.g., gratitude practice; metta practices).
Participants are instructed to be mindful (pay attention) to their current thoughts and feelings and complete ecological momentary assessments of their current psychological stress states (e.g., stress appraisals, affect, perseverative cognitions, self-criticism, social connection)
Eligibility Criteria
You may qualify if:
- female sex and gender identity (to control for sex and gender differences in stress responses and health outcomes)
- age 30-50 (to examine intervention effects on health outcomes in midlife)
- ≥2 Adverse Childhood Experiences (to ensure exposure to early life adversity)
- mild depressive symptoms (to allow for outcome improvements: PHQ-9 ≥ 5)
- having a smartphone (to access app-based assessments/interventions)
You may not qualify if:
- Non-English speaker or unable to provide informed consent
- Current regular mindfulness practice (exclude if \>20 min/week)
- Major psychiatric condition, including psychosis/schizophrenia, bipolar disorder, post-traumatic stress disorder, eating disorders, alcohol/substance use, major depression (PHQ-9 ≥ 15), and self-harm or suicidal ideation
- Major medical conditions, including no history of coronary heart disease, diabetes, severe asthma or lung disease, autoimmune disorders, infectious disease, epilepsy, brain injury, endocrine disorders, diagnosis of cancer or chemotherapy or radiation in the past 10 years
- Free from medications known to affect the immune and endocrine systems with the exception of antidepressant medication and oral contraceptives
- Psychotherapy treatment permitted if stable (≥3 months)
- Current smoking and nicotine use
- Currently pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, San Francisco
San Francisco, California, 94118, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stefanie E Mayer, PhD
University of California, San Francisco
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2022
First Posted
February 24, 2022
Study Start
June 3, 2022
Primary Completion
April 19, 2024
Study Completion
April 19, 2024
Last Updated
May 4, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share